NCT04590105
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
Not specified
Clinical trial condition
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Explore clinical trials studying Precursor Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.
1,801 public trials
304 recruiting studies
Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results
NCT02458235
- Conditions
- Acute Lymphoid Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +18 more
- Locations
-
- University of California San Francisco San Francisco, California, United States
NCT00026780
- Conditions
- Acute Lymphoblastic Leukemia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ewing Sarcoma, +38 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT01913093
- Conditions
- Chemically-Induced Disorders, Childhood Leukemia Survivors, Hematologic Diseases, +13 more
- Locations
-
- The Hospital for Sick Children Toronto, Ontario, Canada
Completed
Peri-operative Hypothermia in Children
NCT03770364
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Hypothermia Following Anesthesia, Sequela, +10 more
- Locations
-
- KK Women's and Children's Hospital Singapore
NCT00137111
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- St Jude Children's Research Hospital Memphis, Tennessee, United States
- Cook Children's Medical Center Fort Worth, Texas, United States
NCT00309842
- Conditions
- Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Anemia, +66 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT00534118
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +58 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Completed
IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT
NCT01885897
- Conditions
- Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Bone Marrow Diseases, +28 more
- Locations
-
- Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
- Washington University St Louis, Missouri, United States
- University of Pennsylvania Philadelphia, Pennsylvania, United States
Completed
Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter
NCT00006083
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +94 more
- Locations
-
- Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States